BioCryst Pharmaceuticals — Post-IPO Debt
BioCryst Pharmaceuticals raised $100.0M in a Post-IPO Debt round. View investors, financials, and press on Fsome.
Round Details
- Funded Company
- BioCryst Pharmaceuticals
- Round Type
- Post-IPO Debt
- Amount Raised
- $100.0M
- Announced
- February 7, 2019
Canonical: https://fsome.com/funding/biocryst-pharmaceuticals-post-ipo-debt-6624184 · For the full investor list, press references, and related rounds, please enable JavaScript.